Forecasts data is unavailable for this security.
Consensus recommendation
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 5 analysts offering 12 month price targets for TriSalus Life Sciences Inc have a median target of 12.00, with a high estimate of 16.00 and a low estimate of 10.00. The median estimate represents a 169.06% increase from the last price of 4.46.
High | 258.7% | 16.00 |
Med | 169.1% | 12.00 |
Low | 124.2% | 10.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Dec 13, 2024.
Average growth rate | +63.27% |
More ▼
Revenue history & estimates in USD
Average growth rate | +13.46% |
More ▼